Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

17.39
Delayed Data
As of 12:03pm ET
 +0.012 / +0.07%
Today’s Change
9.20
Today|||52-Week Range
20.63
-2.40%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close17.38
Today’s open17.32
Day’s range17.10 - 17.65
Volume41,235
Average volume (3 months)328,290
Market cap$606.7M
Dividend yield--
Data as of 12:03pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)-233.33%
Earnings growth (this year)-15.90%
Earnings growth (next 5 years)+9.06%
Revenue growth (last year)+523.58%
P/E ratioNM
Price/Sales691.60
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.13-0.83%
OTICOtonomy Inc-0.07-0.27%
PGNXProgenics Pharmaceut...+0.08+0.93%
COCPCocrystal Pharma Inc-0.03-3.33%
Data as of 12:15pm ET, 08/04/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$767.0K
Annual profit (last year)-$38.8M
Net profit margin-5,060.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
CFO, Treasurer &
Head-Investor Relations
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts